Funding for this research was provided by:
Beijing Science and Technology Planning Project (Z241100009024052)
Beijing Science and Technology Planning Project (Z251100004625024)
National Natural Science Foundation of China (52572310)
State Key Laboratory of Vascular Homeostasis and Remodeling of Peking University
Chinese Postdoctoral Science Foundation (2024M750113)
National Key R&D Program of China (2022YFB3204400)
Article History
Received: 29 September 2025
Revised: 14 December 2025
Accepted: 8 January 2026
First Online: 20 January 2026
Declarations
:
: The clinical trial protocols were approved by the Research Ethics Committee of Peking University First Hospital (approval number: 2024-164).
: The authors declare no competing interests.